On the stock market since 2013, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Red columns mark years that ended in a loss.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $347K a year. A small number, but proof the product has real buyers.
A loss of $0 against $347K in annual sales.
The stock sits at $0.80. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
This stock swings about 2.8 times as much as the market average. Big rallies — and big drops — can both happen fast.
On our five-subject report card, ECGR sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ECGR is a high-risk stock — not yet profitable, and its future rides on its product catching on.